Get started Log in

RNXT — RenovoRx Share News

0.000.00%

Last trade - 00:00

HealthcareMicro CapNeutral

Market Cap
$53.70m
Enterprise Value
$44.23m
Revenue
$1.12m

RenovoRx surges on FDA approval for cancer treatment device
07/09/2021 13:10
Brief: Renovorx Receives New 510(K) Clearance For Its Renovocath Delivery System Designed For Targeted Treatment Of Solid Tumors
07/09/2021 11:47
U.S. STOCKS ON THE MOVE-Globalstar, AC Immune, Spok
31/08/2021 16:01
NASDAQ RESUMED AT 03:44 PM
30/08/2021 20:44
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 03:39 PM
30/08/2021 20:39
NASDAQ RESUMED AT 10:22 AM
30/08/2021 15:22
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:18 AM
30/08/2021 15:18
NASDAQ RESUMED AT 10:10 AM
30/08/2021 15:10
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:08 AM
30/08/2021 15:09
NASDAQ RESUMED AT 09:44 AM
27/08/2021 14:44
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:39 AM
27/08/2021 14:39
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
26/08/2021 08:59
Brief: Renovorx Announces Pricing Of Initial Public Offering
26/08/2021 02:38
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
25/08/2021 08:59
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 03:59 AM
24/08/2021 09:00